PIK3CA and acute myeloid leukemia: However, a BM biopsy on day +223 following transplant revealed relapsed AML with a 10% blast population exhibiting complex cytogenetics and a pathogenic mutation in TP53, as well as variants of unknown significance in FAS, PIK3CA, SETD2, and TET2, with mixed chimerism.